Abstract

A descriptive comparative study design was used to evaluate whether dominant personality characteristic, decision-making style, demographic factors, and/or advanced specialty certification predicted the ability of nurse practitioners to prescribe according to the National Cancer Center Network (NCCN) guidelines for assessment and treatment of cancer pain.

Author Details

Erin McMenamin, PhD, CRNP, Biobehavioral Health, University of Pennsylvania School of Nursing, Philadelphia, Pennsylvania, USA

Sigma Membership

Unknown

Lead Author Affiliation

University of Pennsylvania, Philadelphia, Pennsylvania, USA

Type

Presentation

Format Type

Text-based Document, Video Recording

Study Design/Type

N/A

Research Approach

N/A

Keywords:

Advanced Practice, Oncology, Opioid Prescription, Nurse Practitioners, Oncology Nursing

Conference Name

31st International Nursing Research Congress

Conference Host

Sigma Theta Tau International

Conference Location

Virtual Event

Conference Year

2020

Video/Audio Streaming

Rights Holder

All rights reserved by the author(s) and/or publisher(s) listed in this item record unless relinquished in whole or part by a rights notation or a Creative Commons License present in this item record.

All permission requests should be directed accordingly and not to the Sigma Repository.

All submitting authors or publishers have affirmed that when using material in their work where they do not own copyright, they have obtained permission of the copyright holder prior to submission and the rights holder has been acknowledged as necessary.

Acquisition

Proxy-submission

Additional Files

download (108 kB)

Share

COinS
 

Predictors of nurse practitioner prescription of opioids for cancer patients according to NCCN Guidelines

Virtual Event

A descriptive comparative study design was used to evaluate whether dominant personality characteristic, decision-making style, demographic factors, and/or advanced specialty certification predicted the ability of nurse practitioners to prescribe according to the National Cancer Center Network (NCCN) guidelines for assessment and treatment of cancer pain.